goglides.dev
ResearchFinanceTechCompaniesDiscussion
Search
Sign inJoin
goglidesgoglides.devSocial learning for Finance and Tech.
TermsPrivacyDisclaimerModerationAcceptable UseDMCAContact
Company / Finance

UnitedHealth Group Incorporated

UNH · NYSE

UnitedHealth reported FY2025 revenue of $447.57 billion and Q1 2026 revenue of $111.72 billion, but the official record keeps the thesis tied to medical costs, regulation, Optum execution and cash conversion.

FollowAdd to WatchlistAsk Question
NYSEUNHCoverage BootstrapUnitedHealth Group Incorporated
OverviewFinancialsResearchTimelineCompareValuationScorecardDiscussion
Latest ReportMay 19, 2026UnitedHealth: the healthcare scale giant facing a medical-cost proof testView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->
Company filters1 of 1 reports match
Clear filters
Selected tags
Coverage BootstrapNYSE
Clear tags
MatchAny tagAll tags
Latest Thesis

UnitedHealth: the healthcare scale giant facing a medical-cost proof test

UnitedHealth reported FY2025 revenue of $447.57 billion and Q1 2026 revenue of $111.72 billion, but the official record keeps the thesis tied to medical costs, regulation, Optum execution and cash conversion.

May 19, 2026Research reportSlides available
Read reportOpen slidesDiscussion (0)
UnitedHealth Group Incorporatedthe healthcare scale giant facing a medical-cost proof testMay 19, 2026
Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Sign in to continue

Recent Reports

Compact report index for this company.

View all 1 reports ->
ReportTypeUpdatedReadActions
UnitedHealth: the healthcare scale giant facing a medical-cost proof testUnitedHealth reported FY2025 revenue of $447.57 billion and Q1 2026 revenue of $111.72 billion, but the official record keeps the thesis tied to medical costs, regulation, Optum execution and cash conversion.NYSEMay 19, 2026Research reportReadSlides

Report Sources

No source records are attached to the current company reports.